Dana Investment Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Dana Investment Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,379	Closed	-$307K	–	429
2022 Q4	$307K	Sell	8,379 -62,863	-88%	-$2.48M	0.02%	362
2022 Q3	$3.36M	Sell	71,242 -27,211	-28%	-$1.76M	0.19%	103
2022 Q2	$7.06M	Sell	98,453 -114	-0.1%	-$8.33K	0.36%	75
2022 Q1	$7.98M	Sell	98,567 -200,873	-67%	-$17M	0.37%	72
2021 Q4	$30.7M	Buy	299,440 +16,834	+6%	+$1.62M	1.33%	21
2021 Q3	$24.7M	Buy	+282,606	New	+$25.6M	1.12%	37

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dana Investment Advisors's SYNH Position: Q1 2023 in Review

Dana Investment Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 8,379 shares — an estimated $307K sold.

Dana Investment Advisors first reported a position in SYNH in Q3 2021 and held it in 6 quarters. The position peaked at $30.7M in Q4 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

Dana Investment Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Dana Investment Advisors sold 8,379 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $307K.
Dana Investment Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 6 quarters.
Dana Investment Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $30.7M in Q4 2021.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Dana Investment Advisors's 13F filing for Q1 2023, filed 15 May 2023.